NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 1 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 2,700 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 2,700 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 2,700 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 2,700 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 2,700 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 2,700 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 2,700 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 2,700 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $2,000 | 0.0% | 2,700 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | 0.0% | 2,700 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $2,000 | 0.0% | 2,700 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | – | 2,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 10,375,329 | $13,549,000 | 19.76% |
| Catalyst Capital Advisors LLC | 790,000 | $1,635,000 | 0.53% |
| DSC Advisors, L.P. | 500,000 | $1,035,000 | 0.50% |
| STONERIDGE INVESTMENT PARTNERS LLC | 142,528 | $295,000 | 0.06% |
| Hudock, Inc. | 30,500 | $63,000 | 0.05% |
| BRR OpCo, LLC | 52,700 | $109,000 | 0.05% |
| TFS CAPITAL LLC | 418,074 | $865,000 | 0.04% |
| LifePlan Financial Group, Inc | 28,810 | $60,000 | 0.04% |
| NOMURA HOLDINGS INC | 3,831,177 | $7,947,000 | 0.04% |
| BOLTON LP | 77,400 | $160,000 | 0.03% |